Biocon (NSE:BIOCON) Inventories, Raw Materials & Components: ₹11,615 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:BIOCON Biocon Ltd NSE:BIOCON
87 GF Score
Price ₹434.60
GF Value ₹339.52
Valuation Modestly Overvalued
! 10 Warning Signs
View Full Analysis

What is Biocon Inventories, Raw Materials & Components?

Biocon NSE:BIOCON -0.62% 87 Inventories, Raw Materials & Components is ₹11,615 Mil as of Mar. 2026. GuruFocus rates NSE:BIOCON with a GF Score™ of 87/100 and a GF Value™ of ₹339.52 (Modestly Overvalued). The stock has 10 warning signs investors should review.

Biocon's inventories, raw materials & components for the quarter that ended in Mar. 2026 was ₹11,615 Mil.

Biocon's quarterly raw materials stayed the same from Sep. 2025 (₹0 Mil) to Dec. 2025 (₹0 Mil) but then increased from Dec. 2025 (₹0 Mil) to Mar. 2026 (₹11,615 Mil).

Biocon's annual raw materials increased from Mar. 2024 (₹8,366 Mil) to Mar. 2025 (₹9,679 Mil) and increased from Mar. 2025 (₹9,679 Mil) to Mar. 2026 (₹11,615 Mil).

Biocon Inventories, Raw Materials & Components Historical Data

* Premium members only.

The historical data trend for Biocon's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biocon Inventories, Raw Materials & Components Chart

Biocon Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Inventories, Raw Materials & Components
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8,557.00 8,962.00 8,366.00 9,679.00 11,615.00

Biocon Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9,679.00 0.00 0.00 0.00 11,615.00
NSE:BIOCON
87GF Score
Biocon Ltd NSE:BIOCON
Inventories, Raw Materials & Components is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Biocon Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

What does a Inventories, Raw Materials & Components of ₹11,615 Mil mean?
Biocon (NSE:BIOCON) has a Inventories, Raw Materials & Components of ₹11,615 Mil as of Mar. 2026. Raw materials are the components a company uses for its main products. View historical data on Biocon and its competitors.
Is Biocon's Inventories, Raw Materials & Components too high?
Biocon's current Inventories, Raw Materials & Components is ₹11,615 Mil. Overall, Biocon has a GF Score™ of 87/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Biocon's Inventories, Raw Materials & Components compare to VRTX and REGN?
Biocon's Inventories, Raw Materials & Components of ₹11,615 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Biotechnology company?
A good Inventories, Raw Materials & Components depends on the Biotechnology industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on Biocon and its competitors. Biocon's current Inventories, Raw Materials & Components is ₹11,615 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biocon stock overvalued right now?
Based on GuruFocus' analysis, Biocon (NSE:BIOCON) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹339.52, compared to a current price of ₹434.60 — trading 28% above its estimated fair value. The current Inventories, Raw Materials & Components is ₹11,615 Mil. Biocon's overall GF Score™ is 87/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For Biocon (NSE:BIOCON), the current Inventories, Raw Materials & Components is ₹11,615 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Biocon (NSE:BIOCON) Overvalued in 2026?

Based on GuruFocus' analysis, Biocon stock appears to be overvalued. The current stock price of ₹434.60 is trading 28% above its estimated GF Value™ of ₹339.52. GuruFocus considers Biocon to be Modestly Overvalued.

Key valuation signals for NSE:BIOCON:

  • Inventories, Raw Materials & Components: ₹11,615 Mil
  • GF Value™: ₹339.52 vs. price of ₹434.60 (28% above fair value)
  • GF Score™: 87/100 with 10 warning signs

No single metric tells the full story. See the NSE:BIOCON stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Biocon Business Description

Other Exchanges 532523:India
Address 20th KM, Hosur Road, Electronics City, Bengaluru, KA, IND, 560100
Biocon Ltd is a biopharmaceutical company that develops biotechnology therapies for diseases. The company is focused on developing, manufacturing, and supplying novel and biosimilar pharmaceuticals for diabetes, cancer, and autoimmune conditions. Biocon has four reportable segments: Biosimilars which derives maximum revenue, Generics, Novel Biologics (Novels), and Research services (Research). The company provides integrated contract research and manufacturing services to pharmaceutical and biotechnology companies through its subsidiary Syngene. Geographically, the company generates a majority of its revenue from its customers located in India and the rest from Brazil, Singapore, and the rest of the world.
87GF Score

Get the complete analysis for NSE:BIOCON

Inventories, Raw Materials & Components is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹434.60
Price
₹339.52
GF Value